Showing results (2271-2280 of 2,307) with videos related to
Sort By:
Pageof 231
Bioorganic & Medicinal Chemistry Letters|July 16, 2013
Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1Keith R Hornberger, Dan M Berger, Andrew P Crew, et al.Patient Education and Counseling|September 16, 2019
Impact of patient education videos on genetic counseling outcomes after exome sequencingRebecca Hernan, Megan T Cho, Ashley L Wilson, et al.Clinical Nutrition (Edinburgh, Scotland)|December 17, 2023
The science of micronutrients in clinical practice - Report on the ESPEN symposiumMette M Berger, Karin Amrein, Rocco Barazzoni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer SurveillanceGlenn J Hanna, Scott A Roof, Jamie Jabalee, et al.Clinical Nutrition (Edinburgh, Scotland)|July 7, 2020
Monitoring and parenteral administration of micronutrients, phosphate and magnesium in critically ill patients: The VITA-TRACE surveyWouter Vankrunkelsven, Jan Gunst, Karin Amrein, et al.HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.Critical Care (London, England)|May 17, 2020
Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care MedicineAnnika Reintam Blaser, Jean-Charles Preiser, Sonja Fruhwald, et al.Cancer Letters|February 21, 2025
Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironmentMaryam Abooali, Stephanie Schlichtner, Xi Lei, et al.Molecular Pharmaceutics|September 29, 2023
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal SpraysElham Amini, Simon M Berger, Uta Schilling, et al.Infectious Disorders Drug Targets|November 1, 2007
High throughput crystallography of TB drug targetsA C Murillo, H Y Li, T Alber, et al.Pageof 231